Immune Suppression clinical trials

Explore recruiting immune suppression clinical trials.

Recruiting immune suppression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Immune Suppression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of low-dose Interferon-alfa2a on perioperative immune suppression

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Prevention of secondary infections by interferon gamma in ICU-acquired sustained immune-suppression: a randomized trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Modular, Open Label, Dose Finding Phase 1/2 Clinical Trial in Patients with Solid Tumours to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PTT-4256 (RAISIC-1: Relief of Acidic Immune Suppression In Cancer)

France, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Activity and safety of peptide-based immunotherapy in an umbrella window of opportunity phase II study in patients with squamous cell carcinoma of the head and neck.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

First-in-human safety study of pancreatic islet transplantation without immune suppression in adult subjects with type 1 diabetes

Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Immune Suppression trials by city

Immune Suppression in Toronto Immune Suppression in Vancouver Immune Suppression in Montreal Immune Suppression in Calgary Immune Suppression in Edmonton Immune Suppression in Ottawa Immune Suppression in Winnipeg Immune Suppression in Quebec City Immune Suppression in Hamilton Immune Suppression in Kitchener Immune Suppression in London Immune Suppression in Halifax Immune Suppression in New York Immune Suppression in Los Angeles Immune Suppression in Chicago Immune Suppression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease